Table 1. Immune Drugs Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Immune Drugs Market Restraints

Table 3. Immune Drugs Market Trends

Table 4. Immune Drugs Industry Policy

Table 5. Global Immune Drugs Revenue by Company, 2019-2024, US$ million

Table 6. Global Immune Drugs Revenue Market Share by Company, 2019-2024

Table 7. Global Immune Drugs Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Immune Drugs Sales Volume Market Share by Company, 2019-2024

Table 9. Global Immune Drugs Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Immune Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Immune Drugs Mergers & Acquisitions, Expansion Plans

Table 12. Global Immune Drugs Manufacturers Product Type

Table 13. China Immune Drugs Revenue by Company, 2019-2024, US$ million

Table 14. China Immune Drugs Revenue Market Share by Company, 2019-2024

Table 15. China Immune Drugs Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Immune Drugs Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Immune Drugs Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Immune Drugs Import & Export Trends

Table 19. Main Sources of China Immune Drugs Import

Table 20. Export Destination of China Immune Drugs

Table 21. Global Headquarters and Manufacturing Base of Immune Drugs Manufacturers

Table 22. Global Major Manufacturers, Immune Drugs Capacity Expansion and Future Plans

Table 23. Global Immune Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Immune Drugs Production by Region, 2019-2024, (K Units)

Table 25. Global Immune Drugs Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Immune Drugs Upstream (Raw Materials)

Table 27. Global Immune Drugs Typical Customers

Table 28. Immune Drugs Typical Distributors

Table 29. By Type, Global Immune Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Immune Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Immune Drugs Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Immune Drugs Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Immune Drugs Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Immune Drugs Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Immune Drugs Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Immune Drugs Revenue Market Share, 2019-2030

Table 37. By Country, Global Immune Drugs Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Immune Drugs Sales Volume Market Share, 2019-2030

Table 39. Antares Pharma, Inc. Company Information, Head Office, Market Area and Industry Position

Table 40. Antares Pharma, Inc. Immune Drugs Models, Specifications and Application

Table 41. Antares Pharma, Inc. Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Antares Pharma, Inc. Company Profile and Main Business

Table 43. Antares Pharma, Inc. Recent Developments

Table 44. UCB Company Information, Head Office, Market Area and Industry Position

Table 45. UCB Immune Drugs Models, Specifications and Application

Table 46. UCB Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. UCB Company Profile and Main Business

Table 48. UCB Recent Developments

Table 49. Incyte Company Information, Head Office, Market Area and Industry Position

Table 50. Incyte Immune Drugs Models, Specifications and Application

Table 51. Incyte Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Incyte Company Profile and Main Business

Table 53. Incyte Recent Developments

Table 54. GSK Company Information, Head Office, Market Area and Industry Position

Table 55. GSK Immune Drugs Models, Specifications and Application

Table 56. GSK Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. GSK Company Profile and Main Business

Table 58. GSK Recent Developments

Table 59. Takeda Company Information, Head Office, Market Area and Industry Position

Table 60. Takeda Immune Drugs Models, Specifications and Application

Table 61. Takeda Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Takeda Company Profile and Main Business

Table 63. Takeda Recent Developments

Table 64. 3S Bio Company Information, Head Office, Market Area and Industry Position

Table 65. 3S Bio Immune Drugs Models, Specifications and Application

Table 66. 3S Bio Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. 3S Bio Company Profile and Main Business

Table 68. 3S Bio Recent Developments

Table 69. Horizo​​n Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 70. Horizo​​n Therapeutics Immune Drugs Models, Specifications and Application

Table 71. Horizo​​n Therapeutics Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Horizo​​n Therapeutics Company Profile and Main Business

Table 73. Horizo​​n Therapeutics Recent Developments

Table 74. Bristol-Myers Squibb (BMS Company Information, Head Office, Market Area and Industry Position

Table 75. Bristol-Myers Squibb (BMS Immune Drugs Models, Specifications and Application

Table 76. Bristol-Myers Squibb (BMS Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Bristol-Myers Squibb (BMS Company Profile and Main Business

Table 78. Bristol-Myers Squibb (BMS Recent Developments

Table 79. Astellas Company Information, Head Office, Market Area and Industry Position

Table 80. Astellas Immune Drugs Models, Specifications and Application

Table 81. Astellas Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Astellas Company Profile and Main Business

Table 83. Astellas Recent Developments

Table 84. Eli Lilly Company Information, Head Office, Market Area and Industry Position

Table 85. Eli Lilly Immune Drugs Models, Specifications and Application

Table 86. Eli Lilly Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Eli Lilly Company Profile and Main Business

Table 88. Eli Lilly Recent Developments

Table 89. Mitsubishi Tanabe Pharma Company Information, Head Office, Market Area and Industry Position

Table 90. Mitsubishi Tanabe Pharma Immune Drugs Models, Specifications and Application

Table 91. Mitsubishi Tanabe Pharma Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Mitsubishi Tanabe Pharma Company Profile and Main Business

Table 93. Mitsubishi Tanabe Pharma Recent Developments

Table 94. Biogen Company Information, Head Office, Market Area and Industry Position

Table 95. Biogen Immune Drugs Models, Specifications and Application

Table 96. Biogen Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Biogen Company Profile and Main Business

Table 98. Biogen Recent Developments

Table 99. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 100. Pfizer Immune Drugs Models, Specifications and Application

Table 101. Pfizer Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Pfizer Company Profile and Main Business

Table 103. Pfizer Recent Developments

Table 104. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 105. Sanofi Immune Drugs Models, Specifications and Application

Table 106. Sanofi Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Sanofi Company Profile and Main Business

Table 108. Sanofi Recent Developments

Table 109. Roche Company Information, Head Office, Market Area and Industry Position

Table 110. Roche Immune Drugs Models, Specifications and Application

Table 111. Roche Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 112. Roche Company Profile and Main Business

Table 113. Roche Recent Developments

Table 114. Novartis Company Information, Head Office, Market Area and Industry Position

Table 115. Novartis Immune Drugs Models, Specifications and Application

Table 116. Novartis Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 117. Novartis Company Profile and Main Business

Table 118. Novartis Recent Developments

Table 119. Johnson & Johnson (J&J) Company Information, Head Office, Market Area and Industry Position

Table 120. Johnson & Johnson (J&J) Immune Drugs Models, Specifications and Application

Table 121. Johnson & Johnson (J&J) Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 122. Johnson & Johnson (J&J) Company Profile and Main Business

Table 123. Johnson & Johnson (J&J) Recent Developments

Table 124. Amgen Company Information, Head Office, Market Area and Industry Position

Table 125. Amgen Immune Drugs Models, Specifications and Application

Table 126. Amgen Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 127. Amgen Company Profile and Main Business

Table 128. Amgen Recent Developments

Table 129. Abbvi Company Information, Head Office, Market Area and Industry Position

Table 130. Abbvi Immune Drugs Models, Specifications and Application

Table 131. Abbvi Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 132. Abbvi Company Profile and Main Business

Table 133. Abbvi Recent Developments

List of Figure

Figure 1. Immune Drugs Picture

Figure 2. By Revenue, Global Immune Drugs Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Immune Drugs Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Immune Drugs Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Immune Drugs Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Immune Drugs Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Immune Drugs Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Immune Drugs Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Immune Drugs Share of Global Market, 2019-2030

Figure 10. Global Immune Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Immune Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Immune Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Immune Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Immune Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Immune Drugs Domestic VS Export, 2022

Figure 16. Global Immune Drugs Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Immune Drugs Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Immune Drugs Production Market Share & Forecast by Region, 2019-2030

Figure 19. Immune Drugs Industry Chain

Figure 20. Immune Drugs Procurement Model

Figure 21. Immune Drugs Sales Model

Figure 22. Immune Drugs Sales Channels, Direct Sales and Distribution

Figure 23. Immune Boosting Drugs

Figure 24. Immunosuppressant Drugs

Figure 25. By Type, Global Immune Drugs Revenue, 2019-2030, US$ Million

Figure 26. By Type, Global Immune Drugs Revenue Market Share, 2019-2030

Figure 27. By Type, Global Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 28. By Type, Global Immune Drugs Sales Volume Market Share, 2019-2030

Figure 29. By Type, Global Immune Drugs Price, 2019-2030, (US$/Unit)

Figure 30. Hospital

Figure 31. Clinic

Figure 32. Surgery Center

Figure 33. Others

Figure 34. By Application, Global Immune Drugs Revenue, 2019-2030, US$ Million

Figure 35. By Application, Global Immune Drugs Revenue Market Share, 2019-2030

Figure 36. By Application, Global Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 37. By Application, Global Immune Drugs Sales Volume Market Share, 2019-2030

Figure 38. By Application, Global Immune Drugs Price, 2019-2030, (US$/Unit)

Figure 39. By Region, Global Immune Drugs Revenue Market Share, 2019-2030

Figure 40. By Region, Global Immune Drugs Sales Volume Market Share, 2019-2030

Figure 41. North America Immune Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 42. By Country, North America Immune Drugs Revenue Market Share, 2022

Figure 43. Europe Immune Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, Europe Immune Drugs Revenue Market Share, 2022

Figure 45. Asia Pacific Immune Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 46. By Country/Region, Asia Pacific Immune Drugs Revenue Market Share, 2022

Figure 47. South America Immune Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 48. By Country, South America Immune Drugs Revenue Market Share, 2022

Figure 49. Middle East & Africa Immune Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 50. U.S. Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 51. By Company, U.S. Immune Drugs Market Share, 2022

Figure 52. By Type, U.S. Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 53. By Application, U.S. Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 54. Europe Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 55. By Company, Europe Immune Drugs Market Share, 2022

Figure 56. By Type, Europe Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 57. By Application, Europe Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 58. China Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 59. By Company, China Immune Drugs Market Share, 2022

Figure 60. By Type, China Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 61. By Application, China Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 62. Japan Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 63. By Company, Japan Immune Drugs Market Share, 2022

Figure 64. By Type, Japan Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 65. By Application, Japan Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 66. South Korea Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 67. By Company, South Korea Immune Drugs Market Share, 2022

Figure 68. By Type, South Korea Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 69. By Application, South Korea Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 70. Southeast Asia Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 71. By Company, Southeast Asia Immune Drugs Market Share, 2022

Figure 72. By Type, Southeast Asia Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 73. By Application, Southeast Asia Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 74. India Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 75. By Company, India Immune Drugs Market Share, 2022

Figure 76. By Type, India Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 77. By Application, India Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 78. Middle East & Asia Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 79. By Company, Middle East & Asia Immune Drugs Market Share, 2022

Figure 80. By Type, Middle East & Asia Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 81. By Application, Middle East & Asia Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 82. Research Methodology

Figure 83. Breakdown of Primary Interviews

Figure 84. Bottom-up Approaches

Figure 85. Top-down Approaches